All In Biotech

Drug Trial Radar · NCT06963710

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects With Chronic Hepatitis B Virus Infection (B-SUPREME)

Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Jul 15, 2025

Primary completion

Mar 2027

Study completion Aug 2028

Sponsor

Lead sponsor
Aligos TherapeuticsIndustry
Sponsor type
Industry
First posted
May 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 study to evaluate efficacy and safety of 48 weeks of oral once daily monotherapy with ALG-000184 versus tenofovir disproxil fumarate (TDF) for chronic HBV infection.

Conditions

  • Chronic Hepatitis B Infection

Interventions

  • ALG-000184Drug

    300 mg tablet

  • TDFDrug

    300 mg tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HBeAg positive: HBV DNA <Lower Limit of Quantification [LLOQ] (10 IU/mL, target detected or target not detected)Time frame: 48 weeks
  2. HBeAg negative: HBV DNA <Lower Limit of Quantification [LLOQ] (10 IU/mL, target not detected)Time frame: 48 weeks

Locations

41 sites in 14 countries. Site status is shown where the registry gives one.

  • Aligos Investigational Site

    Coronado, California

  • Aligos Investigational Site

    Pasadena, California

  • Aligos Investigational Site

    Rialto, California

  • Aligos Investigational Site

    San Francisco, California

  • Aligos Investigational Site

    San Jose, California

  • Aligos Investigational Site

    Miami, Florida

  • Aligos Investigational Sites

    Sofia, Bulgaria

  • Aligos Investigational Site

    Edmonton, Canada

  • Aligos Investigational Site

    Ottawa, Canada

  • Aligos Investigational Site

    Toronto, Canada

  • Aligos Investigational Sites

    Vancouver, Canada

  • Aligos Investigational Sites

    Beijing, China

  • Aligos Investigational Site

    Changchun, China

  • Aligos Investigational Site

    Chengdu, China

  • Aligos Investigational Site

    Chongqing, China

  • Aligos Investigational Sites

    Guangzhou, China

  • Aligos Investigational Site

    Nanjing, China

  • Aligos Investigational Sites

    Shanghai, China

  • Aligos Investigational Site

    Clichy, France

  • Aligos Investigational Site

    Limoges, France

  • Aligos Investigational Site

    Nice, France

  • Aligos Investigational Site

    Toulouse, France

  • Aligos Investigational Sites

    Hong Kong, Hong Kong

  • Aligos Investigational Site

    Milan, Italy

  • Aligos Investigational Site

    Chisinau, Moldova

  • Aligos Investigational Site

    Auckland, New Zealand

  • Aligos Investigational Sites

    Bucharest, Romania

  • Aligos Investigational Site

    Ansan, South Korea

  • Aligos Investigational Site

    Busan, South Korea

  • Aligos Investigational Sites

    Seoul, South Korea

  • Aligos Investigational Site

    Ulsan, South Korea

  • Aligos Investigational Site

    Yangsan, South Korea

  • Aligos Investigational Site

    Pontevedra, Spain

  • Aligos Investigational Site

    Chiayi City, Taiwan

  • Aligos Investigational Site

    Kaohsiung City, Taiwan

  • Aligos Investigational Site

    Taichung, Taiwan

  • Aligos Investigational Site

    Tainan, Taiwan

  • Aligos Investigational Site

    Taipei, Taiwan

  • Aligos Investigational Site

    Glasgow, United Kingdom

  • Aligos Investigational Site

    Leicester, United Kingdom

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.